<DOC>
	<DOCNO>NCT01243658</DOCNO>
	<brief_summary>RCT . Two substudies ( clinical experimental ) . Main objective trial examine oxytocin , compare placebo show additional effect therapy achievement ( outcome ) patient borderline personality disorder , receive in-patient standard psychotherapy ( Dialectical-behavioral-therapy , Marsha Linehan ( 2006 ) ) . Secondary objective : Investigate oxytocin compare placebo enhances social trust emotion recognition patient borderline personality disorder . Comparison effect Oxytocin patient BPD major depression .</brief_summary>
	<brief_title>`` The Effects Oxytocin Patients With Borderline Personality Disorder ''</brief_title>
	<detailed_description />
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Gender : Both , male female Minimum Age : 18 Years Maximum Age : 50 Years Borderline personality disorder major depression ( clinical control group ) Mini Mental Status Test &gt; 27 ( capacity consent ) chronic acute somatic health problem Schizophrenia Bipolar affective disorder pregnancy breast feed neurological disorder allergy antidegradants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Oxytocin</keyword>
	<keyword>BPD</keyword>
	<keyword>Borderline</keyword>
</DOC>